GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shanghai Labway Clinical Laboratory Co Ltd (SZSE:301060) » Definitions » ROCE %

Shanghai Labway Clinical Laboratory Co (SZSE:301060) ROCE % : 0.96% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Labway Clinical Laboratory Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Labway Clinical Laboratory Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.96%.


Shanghai Labway Clinical Laboratory Co ROCE % Historical Data

The historical data trend for Shanghai Labway Clinical Laboratory Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Labway Clinical Laboratory Co ROCE % Chart

Shanghai Labway Clinical Laboratory Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only 10.58 14.80 21.40 45.36 -6.45

Shanghai Labway Clinical Laboratory Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.73 -5.59 2.95 -27.12 0.96

Shanghai Labway Clinical Laboratory Co ROCE % Calculation

Shanghai Labway Clinical Laboratory Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-145.073/( ( (3746.874 - 1413.821) + (2986.861 - 822.829) )/ 2 )
=-145.073/( (2333.053+2164.032)/ 2 )
=-145.073/2248.5425
=-6.45 %

Shanghai Labway Clinical Laboratory Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=20.668/( ( (2986.861 - 822.829) + (2894.81 - 739.681) )/ 2 )
=20.668/( ( 2164.032 + 2155.129 )/ 2 )
=20.668/2159.5805
=0.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Labway Clinical Laboratory Co  (SZSE:301060) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Shanghai Labway Clinical Laboratory Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Labway Clinical Laboratory Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Labway Clinical Laboratory Co (SZSE:301060) Business Description

Traded in Other Exchanges
N/A
Address
Lane 268, Linxin Road, Floor 6, 7, 8, 9 of Building 1, Changning District, Shanghai, CHN, 200335
Labway Clinical Laboratory (Shanghai) Ltd provides comprehensive health management solutions relying on medical laboratory and pathological diagnosis services. It offers genetic testing, clinical microbiology testing, blood and pathology testing, cytopathological diagnosis and other services.
Executives
Sun Lin Jie Director

Shanghai Labway Clinical Laboratory Co (SZSE:301060) Headlines

No Headlines